Giuseppe Crisafulli
Biographic Data
| ID | 3075976 |
|---|---|
| NAME | Giuseppe Crisafulli |
| GIVEN NAMES | Giuseppe |
| FAMILY NAME | Crisafulli |
| SIGNATURE | CRISAFULLI G |
| AFFILIATIONS | Istituto Ortopedico Gaetano Pini |
| ORCID | 0000-0001-5602-8668 |
| VERIFIED | Yes |
| TOTAL WORKS | 3 |
| TOTAL CITATIONS | 3 |
| AUTHOR COUNT | 3 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2024 |
| H-INDEX | 1 |
Association between Second-Hand Exposure to E-Cigarettes at Home and Exacerbations in Children with Asthma
Several studies have shown the effects of e-cigarettes in adults. Nowadays, few data are available in the pediatric population. This study aims to assess the relationship between asthma exacerbations and home exposure to e-cigarettes. We conducted a pilot, retrospective, monocenter, observational study. Demographic and clinical data were collected, including number of asthma exacerbations, need for rescue therapy and/or therapeutic step-up, and A…
Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study
Our findings validate omalizumab and dupilumab as effective and safe therapeutic options for managing moderate-to-severe allergic diseases in children and adolescents
Linguistic Measures of the Therapeutic Process in Carl Rogers's Case of Miss Vib
Linguistic Measures of the Therapeutic Process in Carl Rogers's Case of Miss Vib
Association between Second-Hand Exposure to E-Cigarettes at Home and Exacerbations in Children with Asthma
Several studies have shown the effects of e-cigarettes in adults. Nowadays, few data are available in the pediatric population. This study aims to assess the relationship between asthma exacerbations and home exposure to e-cigarettes. We conducted a pilot, retrospective, monocenter, observational study. Demographic and clinical data were collected, including number of asthma exacerbations, need for rescue therapy and/or therapeutic step-up, and A…
Early Assessment of Efficacy and Safety of Biologics in Pediatric Allergic Diseases: Preliminary Results from a Prospective Real-World Study
Our findings validate omalizumab and dupilumab as effective and safe therapeutic options for managing moderate-to-severe allergic diseases in children and adolescents
Asthma (2 works) · Asthma and respiratory diseases (2 works) · Cohort (2 works) · Internal Medicine (2 works) · Medicine (2 works) · Pediatrics (2 works) · Population (2 works) · Academic and Historical Perspectives in Psychology (1 works) · Adverse effect (1 works) · Air Quality and Health Impacts (1 works)